Home / Companies / Outlook Therapeutics, Inc. / 7 Mar 2024
Outlook Therapeutics, Inc.: meeting of 7 Mar 2024
Votes reported on Form N-PX, item by item
99 Form N-PX filers reported votes at the Outlook Therapeutics, Inc. meeting of 7 Mar 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
4 nominees; 69.7% of reported votes for; 25 filers withheld from or voted against at least one nominee.
244 vote records from 37 filers. 0 of the 37 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
139 vote records from 99 filers. 6 of the 95 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.
0 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
61 vote records from 37 filers. 0 of the 37 filers that marked the item either way voted against management.
0 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
244 vote records from 37 filers. 4 of the 37 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
61 vote records from 37 filers. 3 of the 37 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | Split or no vote | For | For |
| State Street and SPDR | Split or no vote | For | For |
| Invesco | No report | For | No report |
| Equitable | For | For | For |
| Charles Schwab | For | For | For |
| ProShares and ProFunds | Split or no vote | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | Against * | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | No report | For | No report |
| PGIM and Prudential | No report | For | No report |
| Northern Trust and FlexShares | For | For | For |
| SEI | Split or no vote | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | Split or no vote | For | For |
| Voya | Split or no vote | For | For |
| Nationwide | Split or no vote | For | For |
| Victory Capital | Split or no vote | For | For |
| Guggenheim and Rydex | Split or no vote | For | For |
| BNY Mellon | No report | For | No report |
| Principal | Split or no vote | For | For |
| Pacific Life funds | For | For | For |
| Global X | Split or no vote | For | For |
| AllianceBernstein | No report | For | No report |
| DWS | Split or no vote | For | For |
| Janus Henderson | No report | For | No report |
| Neuberger Berman | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Outlook Therapeutics, Inc. meeting?
99 Form N-PX filers reported votes at the meeting of 7 Mar 2024. On say-on-pay, 6 of 95 voted against management (6.3%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Outlook Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Outlook Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Outlook Therapeutics, Inc. with a meeting date within three days of 7 Mar 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.